Valuation Latigo Biotherapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-01 EDT			5-day change	1st Jan Change
16.69 ^USD	-0.06%		-16.42%	-

09-20	Latigo Biotherapeutics, Inc.(NasdaqGS:LTGO) added to S&P TMI Index	CI
09-03	Latigo Biotherapeutics Q2 Net Loss Narrows	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	1,107	-	-
Change	-	-	-
Enterprise Value (EV) ¹	756.6	892	895.9
Change	-	17.89%	0.44%
P/E	-5.55x	-7.21x	-5.53x
PBR	-	-	-
PEG	0.1x	0.3x	-0.2x
Capitalization / Revenue	-	-	52.8x
EV / Revenue	-	-	42.7x
EV / EBITDA	-5.21x	-5.76x	-2.67x
EV / EBIT	-5.2x	-5.26x	-3.51x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-3.01	-2.318	-3.02
Distribution rate	-	-	-
Net sales ¹	-	-	20.96
EBITDA ¹	-145.3	-154.8	-335.7
EBIT ¹	-145.4	-169.5	-255.1
Net income ¹	-142.6	-161.2	-235.9
Net Debt ¹	-350.6	-215.2	-211.3
Reference price ²	16.70	16.70	16.70
Nbr of stocks (in thousands)	66,299	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LATIGO BIOTHERAPEUTICS, INC.	-5.55x	-	-5.21x	-	1.11B
WUXI APPTEC CO., LTD.	21.73x	7.77x	15.61x	1.37%	74.46B
ARGENX SE	31.25x	9.01x	28.06x	0.04%	60.14B
LONZA GROUP AG	33.64x	6.03x	18.07x	0.97%	48.15B
IQVIA HOLDINGS INC.	34.63x	3.34x	14.4x	-.--%	44.25B
REVOLUTION MEDICINES, INC.	-21.16x	229.18x	-22.81x	-.--%	43.99B
BEONE MEDICINES AG	47.94x	5.54x	30.43x	-.--%	41.61B
CELLTRION, INC.	26.89x	7.76x	19.96x	0.42%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	33.91x	7.26x	18.84x	-.--%	29.31B
INSMED INCORPORATED	-70.02x	13.44x	-68.51x	-.--%	24.93B
Average	13.33x	32.15x	4.88x	0.31%	39.79B
Weighted average by Cap.	19.51x	31.88x	10.19x	0.41%